Open Access
CC BY-NC-ND 4.0 · Laryngorhinootologie 2021; 100(S 02): S122-S123
DOI: 10.1055/s-0041-1727963
Abstracts
Head-Neck-Oncology: HPV / Tumor Marker

RNA-sequencing reveals an immune “hot” gene expression signature in oropharyngeal squamous cell carcinoma which is upregulated upon decitabine treatment in cell lines

Authors

  • J Ezic

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • A von Witzleben

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • A Fehn

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • M Bens

    3   Leibniz Institute on Aging - Fritz Lipmann Institute, Jena

  • J Thomas

    2   Faculty of Medicine, Cancer Sciences Unit, Southampton, United Kingdom

  • O Ammerpohl

    4   Ulm University Medical Center, Institute for Human Genetics, Ulm

  • J Kolarova

    4   Ulm University Medical Center, Institute for Human Genetics, Ulm

  • H Kestler

    5   Ulm University, Institute for Medical Systems Biology, Ulm

  • J Kraus

    5   Ulm University, Institute for Medical Systems Biology, Ulm

  • J Döscher

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • P Schuler

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • J Greve

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • R Marienfeld

    6   Ulm University Medical Center, Institute for Pathology, Ulm

  • T Barth

    6   Ulm University Medical Center, Institute for Pathology, Ulm

  • P Möller

    6   Ulm University Medical Center, Institute for Pathology, Ulm

  • A Kleger

    7   Ulm University Medical Center, Department of Internal Medicine I, Ulm

  • M-N Theodoraki

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • M Brand

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • C Brunner

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • T Hoffmann

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm

  • C Ottensmeier

    2   Faculty of Medicine, Cancer Sciences Unit, Southampton, United Kingdom

  • S Laban

    1   Ulm University Medical Center, Department of Otorhinolaryngology and Head & Neck Surgery, Ulm
Weitere Informationen
Auch verfügbar auf
 

Content Introduction A significant percentage of oropharyngeal squamous cell carcinoma (OPSCC) is human papillomavirus (HPV) driven. HPV-positive OPSCC have a prognostic advantage likely due to cancer-specific immunity. We aimed to identify expression patterns of immune-related genes to assign “hot”and “cold” tumors.

Material and Methods RNA sequencing was performed in 51 patients (Cohort 1, HPV-: n=19, HPV+: n=32), and in 6 HNSCC cell lines (HPV-: n=3, HPV+: n=3). Cell lines were treated with 2µM decitabine (DAC) or control-treated (DMSO). A validation cohort was obtained from The Cancer Genome Atlas (TCGA, Cohort 2, HPV-: n=18, HPV+: n=48). Differential gene expression analysis was performed using deseq2 (1.29.16), and gene ontology using clusterProfiler (3.18.0) R packages.

Results An immune signature (n=32 genes) was developed based on the comparison of CD8high/low and CD103high/low tumors in Cohort 1 and validated in cohort 2. The signature was cross-validated and refined using a previously established signature to define “hot”and “cold” tumors resulting in a 47 gene immune signature. Differential gene expression analysis confirmed an upregulation of immune-related genes in “hot”tumors (n=428 genes). That gene set was further analyzed in HNSCC cell lines +/- DAC treatment. Differential gene expression analysis showed that DAC treatment leads to an increase of immune-related gene expression in-vitro, which was confirmed by gene ontology analysis.

Conclusions Based on our findings, it seems that DAC treatment causes an increase in expression of immune-relate genes which could lead to increased tumor immunogenicity and may enhance immunotherapy results.

Poster-PDF A-1581.pdf



Publikationsverlauf

Artikel online veröffentlicht:
13. Mai 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany